Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $86.64 --0%
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.68), $0.11 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $32.41 million versus the consensus estimate of $49.23 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
